Temporal Associations of Plasma Levels of the Secreted Phospholipase A 2 Family and Mortality in Severe COVID-19.
Temporal Associations of Plasma Levels of the Secreted Phospholipase A 2 Family and Mortality in Severe COVID-19.
复制标题
分泌型磷脂酶 A 2 家族血浆水平与严重 COVID-19 死亡率的时间关联。
DOI:
10.1101/2022.11.21.22282595
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
Chilton,FloydH
中科院分区:
文献类型:
--
作者:
Lu,Eric;Hara,Aki;Sun,Shudong;Hallmark,Brian;Snider,JustinM;Seeds,MichaelC;Watkins,JosephC;McCall,CharlesE;Zhang,HaoHelen;Yao,Guang;Chilton,FloydH
Previous research suggests that group IIA‐secreted phospholipase A2(sPLA2‐IIA) plays a role in and predicts lethal COVID‐19 disease. The current study reanalyzed a longitudinal proteomic data set to determine the temporal relationship between levels of several members of a family of sPLA2isoforms and the severity of COVID‐19 in 214 ICU patients. The levels of six secreted PLA2isoforms, sPLA2‐IIA, sPLA2‐V, sPLA2‐X, sPLA2‐IB, sPLA2‐IIC, and sPLA2‐XVI, increased over the first 7 ICU days in those who succumbed to the disease but attenuated over the same time period in survivors. In contrast, a reversed pattern in sPLA2‐IID and sPLA2‐XIIB levels over 7 days suggests a protective role of these two isoforms. Furthermore, decision tree models demonstrated that sPLA2‐IIA outperformed top‐ranked cytokines and chemokines as a predictor of patient outcome. Taken together, proteomic analysis revealed temporal sPLA2patterns that reflect the critical roles of sPLA2isoforms in severe COVID‐19 disease.